Emergent BioSolutions Inc.

NYSE:EBS

8.1 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042001
Operating Activities:
Net Income -760.5-223.8230.9305.154.562.782.59451.77662.8736.74130.25918.14316.11347.18426.54520.68222.93622.79315.78411.472230.9
Depreciation & Amortization 125.1143.3123.8114.5110.762.242.57238.22935.33532.45318.95811.1979.3555.994.9994.9644.8174.7153.5491.867123.8
Deferred Income Tax -8.9-1946.9-2.4-1.68.63.2595.193.46416.49313.8583.38320.18810.9297.6042.0065.5890.987-10.968-0.41846.9
Stock Based Compensation 23.145.142.451.826.723.215.21318.47715.84812.82911.23811.11510.7397.0635.0072.5100.7230042.4
Change In Working Capital -70.30.5-156.48.8-39.9-119.153.724-45.45-65.90413.54124.143-12.832-46.48121.87-26.396-21.37425.543-32.9947.295-4.459-94.7
Accounts Receivables -21.6114.7-48.249-8.2-94.2-4.81-22.446-64.35121.40535.456-21.89-34.87319.094-30.017-6.0380-40.80100-48.2
Inventory 0.6-51.9-44-83.2-16.7-1.96.066-9.026-11.2624.2290.518-0.5-1.9390.7996.207-2.8317.825-8.28-3.189-1.609-44
Accounts Payables 10.6-14-2.519.816.5-716.134-14.7914.749-9.279-0.5510.2742.513.623-1.334-0.45705.80100-2.5
Other Working Capital -59.9-48.3-61.723.2-31.5-1636.3340.8134.96-2.814-11.289.284-12.179-1.646-1.252-12.04817.71810.28610.484-2.8594.7
Other Non Cash Items 485.219.833.55937.64.210.777-14.735-7.1540.261-1.4888.6374.6796.50712.752-1.471-3.462-0.285-0.0170.491-28.2
Operating Cash Flow -206.3-34.1321.153618841.8208.13953.48744.459112.31896.96839.64314.59399.54330.5117.31755.447-4.06142.259.196321.1
Investing Activities:
Investments In Property Plant And Equipment -51.6-115.8-225-141-86.9-72.1-54.828-76.257-44.812-30.673-42.021-53.845-54.026-22.101-33.287-20.813-43.969-41.228-6.532-17.072-225
Acquisitions Net 270.20000-827.7-195.10-0.65-179.379-25.87300-17.873000-0.218-0.55900
Purchases Of Investments 000000000000-4.187-16.5180000000
Sales Maturities Of Investments 000000000001.9664.2516.518000000.1470
Other Investing Activites -6.3-265.50-10-102.6-195.104000-67.89411.765016.5180-10-43.969-0.1921.25-1.250
Investing Cash Flow 212.3-381.3-225-151-96.9-897.2-249.932-76.257-45.462-210.052-67.894-40.114-53.963-23.456-33.287-30.813-43.969-41.638-5.841-18.175-225
Financing Activities:
Debt Repayment -543.4564.2-35.962.913.7795.2-2002180.588-0.7743.3212.028-18.2918.535-0.75115.02530.861-0.95611.7550
Common Stock Issued 8.40031.68.20017.125000010.0267.2354.4643.3912.47154.8190.0330.0120
Common Stock Repurchased 0-82.1-106-13.8-7.4-0.1-33.1-1.1-0.1-0.2-0.213-5.906061.204000-0.192-0.337-0.665-106
Dividends Paid 000000000000000000-5.400
Other Financing Activities -0.7-0.90.96.6-49.6-6.41.7-18.64131.54918.4869.5990.8212.2231.6981.8456.3280.9950.5320-2.421-141
Financing Cash Flow -535.7481.2-14169.5-35.9788.7-51.401-18.64133.449198.8748.612-1.76514.251-9.35814.8448.96818.49186.02-6.668.681-141
Other Information:
Effect Of Forex Changes On Cash -1.20.5-0.3-10.4-0.2-0.0270.129-0.150.021-0.0140.0010.001-0.634-0.6170.271-0.657-0.197-0.2760-0.3
Net Change In Cash -530.966.3-45.2453.555.6-66.9-93.221-41.28232.296101.16137.672-2.235-25.11866.09511.451-14.25729.31240.12429.473-0.298-45.2
Cash At End Of Period 111.7642.6576.3621.5168112.4178.292271.513312.795280.499179.338141.666143.901169.019102.92491.473105.7376.41836.2946.821576.3